HIF1A and neoplasm: Owing to the PDT and HIF-1α inhibiting effect, TPPa-Y NPs exhibited a high in vivo tumor growth inhibition rate (96.3%), and could greatly inhibit the expression of HIF-1α within a solid tumor.